- Broad Spectrum DNA Delivery– Achieve high expression levels in multiple breast cancer cell types
- Formulated for Low Cellular Toxicity– Maintain cell density and reduce experimental biases due to toxicity
- Superior Transfection Efficiency– TransIT®-BrCa outperforms Lipofectamine® 2000, in various breast cancer cell lines
- TransIT-BrCa Transfection Reagent Exhibits Higher Luciferase Expression in Breast Cancer Cells Compared to Other Transfection Reagents
- High Efficiency Delivery of Plasmid DNA in Breast Cancer Cell Types
- TransIT-BrCa Transfection Reagent Yields High Efficiency Plasmid DNA Transfection
- Activation of Estrogen Receptor Pathway is Detected in MCF-7 Cells Transfected with TransIT- BrCa Transfection Reagent
Storage Conditions:
All Configurations: Store at -20°C
Product Guarantee:
All Configurations: 1 year
Reviews
There are no reviews yet.